Financials

News Discussions Technicals Forecast Seasonals

002675 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Yantai Dongcheng Biochemicals Co., Ltd. engages in the research, development, production and sales of heparin sodium bulk drug and chondroitin sulfate. The company main product series include API, Preparation and Nuclide Drug Series. It manufactures active pharmaceutical ingredient, nuclear medicine, chemical synthetic drugs and modern Chinese medicines. The company’s products include heparin, chondroitin sulphate, marine collagen, hyaluronic acid, glucosamine, heparinoid and cytochrome C. Yantai Dongcheng Biochemicals was founded on December 31, 1998 and is headquartered in Yantai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

002675 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company